Considering the significant anti-tumor and pro-osteogenic effects of IL-27 and cabo combination therapy, RNA-sequencing was used to further elucidate the mechanisms contributing to the therapeutic effects of these agents utilizing an in vivo intratibial TC2Ras model. This evidence concerns the gene IL27 and neoplasm.